| Dr Yudy Astrid Fonseca, MD | |
|
22 S Greene St, Baltimore, MD 21201-1544 | |
| (410) 328-6957 | |
| (410) 328-0680 |
| Full Name | Dr Yudy Astrid Fonseca |
|---|---|
| Gender | Female |
| Speciality | Pediatrics - Pediatric Critical Care Medicine |
| Location | 22 S Greene St, Baltimore, Maryland |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1043641921 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208000000X | Pediatrics | D83600 (Maryland) | Secondary |
| 2080P0203X | Pediatrics - Pediatric Critical Care Medicine | D83600 (Maryland) | Primary |
| Entity Name | University Of Maryland Pediatric Associates, Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1528163912 PECOS PAC ID: 6800888678 Enrollment ID: O20040401000195 |
News Archive
Tendyne Holdings, Inc., a privately held clinical stage medical device company, announced today that in November 2014 the Tendyne Transcatheter Mitral Valve Implantation system (TMVI) was successfully implanted in the first patient of the Tendyne Feasibility Study. This was the first patient enrolled in a three continent, multicenter trial, which aims to generate insight into the safety and performance of the Tendyne device in inoperable patients suffering from mitral regurgitation.
Results from an ongoing surveillance study, PROTEKT US (Prospective Resistant Organism Tracking and Epidemiology of the Ketolide Telithromycin – United States) Year 2 (2001-2002), suggest that KETEK® (telithromycin) is highly active in vitro against Streptococcus pneumoniae (S. pneumoniae) isolates, including those resistant to other antimicrobial agents.
Fast-track recruitment has begun for a trial to investigate the safety of a vaccine against H5N1 avian influenza, the National Institute of Allergy and Infectious Diseases (NIAID) announced today.
Catheter-directed therapy or catheter-directed thrombolysis-an interventional radiology treatment that uses targeted image-guided drug delivery with specially designed catheters to dissolve dangerous blood clots in the lungs-saves lives and should be considered a first-line treatment option for massive pulmonary embolism, note researchers in the November Journal of Vascular and Interventional Radiology.
Hepatocellular carcinoma (HCC), the primary cancer of the liver, is on the verge of becoming an epidemic among Mexican Americans, especially in Texas.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Yudy Astrid Fonseca, MD P.o. Box 62063, Baltimore, MD 21264-2063 Ph: (410) 706-5181 | Dr Yudy Astrid Fonseca, MD 22 S Greene St, Baltimore, MD 21201-1544 Ph: (410) 328-6957 |
News Archive
Tendyne Holdings, Inc., a privately held clinical stage medical device company, announced today that in November 2014 the Tendyne Transcatheter Mitral Valve Implantation system (TMVI) was successfully implanted in the first patient of the Tendyne Feasibility Study. This was the first patient enrolled in a three continent, multicenter trial, which aims to generate insight into the safety and performance of the Tendyne device in inoperable patients suffering from mitral regurgitation.
Results from an ongoing surveillance study, PROTEKT US (Prospective Resistant Organism Tracking and Epidemiology of the Ketolide Telithromycin – United States) Year 2 (2001-2002), suggest that KETEK® (telithromycin) is highly active in vitro against Streptococcus pneumoniae (S. pneumoniae) isolates, including those resistant to other antimicrobial agents.
Fast-track recruitment has begun for a trial to investigate the safety of a vaccine against H5N1 avian influenza, the National Institute of Allergy and Infectious Diseases (NIAID) announced today.
Catheter-directed therapy or catheter-directed thrombolysis-an interventional radiology treatment that uses targeted image-guided drug delivery with specially designed catheters to dissolve dangerous blood clots in the lungs-saves lives and should be considered a first-line treatment option for massive pulmonary embolism, note researchers in the November Journal of Vascular and Interventional Radiology.
Hepatocellular carcinoma (HCC), the primary cancer of the liver, is on the verge of becoming an epidemic among Mexican Americans, especially in Texas.
› Verified 7 days ago
Hilary Tamara Wolf, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 22 S Greene St, Baltimore, MD 21201 Phone: 410-328-7373 Fax: 410-328-7305 | |
Dr. Carmel Bogle, M.D. Pediatrics Medicare: Accepting Medicare Assignments Practice Location: 1800 Orleans St, Baltimore, MD 21287 Phone: 443-287-0526 Fax: 410-955-0897 | |
Anna Eunjoo Choe, Pediatrics Medicare: Medicare Enrolled Practice Location: 615 N Wolfe St Rm Wb602, Baltimore, MD 21205 Phone: 410-955-3362 Fax: 410-614-1582 | |
Dr. Melissa Lauren Shapiro, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 2411 W Belvedere Ave Ste 407, Baltimore, MD 21215 Phone: 410-601-8663 | |
Dr. Alexander James Jaksic, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 600 N Wolfe St, Baltimore, MD 21287 Phone: 781-223-0948 | |
Adam J Spanier, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 300 Armory Pl, Baltimore, MD 21201 Phone: 410-225-8780 Fax: 410-225-8766 | |
Milagritos D Tapia, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 22 S Greene St, Baltimore, MD 21201 Phone: 410-328-6749 Fax: 410-328-6136 |